The comparative analysis of BCR-ABL/ABL detection by real-time quantitative PCR and automated GeneXpert Dx System in chronic myeloid leukemia patients with major and complete molecular response

The comparative analysis of BCR-ABL/ABL detection by real-time quantitative PCR and automated GeneXpert Dx System in chronic myeloid leukemia patients with major and complete molecular response

Key words: chronic myeloid leukemia, BCR-ABL expression, automated GeneXpert method

Saved in:

Bibliographic Details
Main Authors:	S. A. Smirnikhina, G. A. Tsaur, E. Yu. Chelysheva, Yu. A. Yakovleva, A. V. Lavrov, A. O. Аbdullaev, N. V. Bederak, O. A. Shukhov, A. G. Solodovnikov, A. M. Popov, E. P. Adilgereeva, L. G. Fechina, A. G. Turkina, S. I. Kutsev
Format:	Article
Language:	Russian
Published:	ABV-press 2014-07-01
Series:	Онкогематология
Subjects:	chronic myeloid leukemia bcr-abl expression automated genexpert method
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/21
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Diagnostic contribution of GeneXpert Ultra in pediatric pulmonary tuberculosis
by: Claudia Stella Pereira Battaglia, et al.
Published: (2025-03-01)

Role of GeneXpert MTB/RIF assay for the diagnosis of cervical lymph node tuberculosis and rifampicin resistance
by: Sahjid Mukhida, et al.
Published: (2022-01-01)

Test agreement between GeneXpert and urine lipoarabinomannan test for tuberculosis diagnosis among children in Ethiopia
by: Daniel Derese, et al.
Published: (2025-03-01)

Change in TB diagnostic profile after introduction of GeneXpert MTB/RIF assay in National TB Program of Armenia, 2013-2017
by: Eduard Kabasakalyan, et al.
Published: (2019-05-01)

Cartridge-based nucleic amplification (CBNAAT)/GeneXpert test as a diagnostic modality for the detection of genital tuberculosis in women with infertility
by: Shaozae, Chavini K., et al.
Published: (2025-07-01)

Role of Chest Radiography in Diagnosing Pulmonary Tuberculosis, Does Every Suspected Case Needs GeneXpert MTB; A Cross-Sectional Study
by: Mujahid Raza, et al.
Published: (2025-02-01)

Role of Chest Radiography in Diagnosing Pulmonary Tuberculosis, Does Every Suspected Case Needs GeneXpert MTB; A Cross-Sectional Study
by: Mujahid Raza, et al.
Published: (2025-02-01)

Utility of GeneXpert MTB/RIF assay for the diagnosis of pulmonary and extra-pulmonary tuberculosis, A report from Egypt
by: Enas, M. Hefzy, et al.
Published: (2021-02-01)

The performance of GeneXpert® PCR assay in detecting group B streptococcus colonization at labor
by: Mohammed Rohi Khalil, et al.
Published: (2021-06-01)

Predictors of cerebrospinal fluid GeneXpert MTB/RIF positivity in patients with tuberculous meningitis: A prospective cohort study
by: Priyanka Gupta, et al.
Published: (2024-10-01)

Prevalence of toxigenic Clostridium difficile in hospitalized patients in the southwestern province of Saudi Arabia: Confirmation using the GeneXpert analysis
by: Nader Kameli, et al.
Published: (2024-12-01)

Mycobacterium tuberculosis Detection in Diverse Clinical Specimens by GeneXpert MTB/RIF: A Large-Scale Retrospective Study
by: Li H, et al.
Published: (2025-05-01)

Real-Life Diagnostic Accuracy and Clinical Utility of Hepatitis B Virus (HBV) Nucleic Acid Testing Using the GeneXpert Point-of-Care Test System from Fresh Plasma and Dry Blood Spot Samples in The Gambia
by: Amie Ceesay, et al.
Published: (2024-11-01)

Comparison of the Performances of the Accunome DXcellence and Cepheid GeneXpert Assays in Detecting Influenza A and B Viruses and Respiratory Syncytial Virus in Nasopharyngeal Swab
by: Hui Hu, et al.
Published: (2025-03-01)

Association of Clinical Features and Hematological Laboratories between Ph (+)/BCR-ABL (+) Chronic Myeloid Leukemia and Other Type of Ph/BCR-ABL Chronic Myeloid Leukemia
by: Wulyo Rajabto, et al.
Published: (2018-03-01)

Computational Insights into the Polypharmacological Landscape of BCR-ABL Inhibitors: Emphasis on Imatinib and Nilotinib
by: Rima Hajjo, et al.
Published: (2025-06-01)

Current and future of targeted therapies against BCR::ABL kinases
by: Sridhar Jayavel, et al.
Published: (2025-04-01)

Precision Medicine in BCR-ABL1 Negative Myeloproliferative Neoplasms
by: Linet Njue, et al.
Published: (2020-12-01)

Clinicopathological spectrum of BCR-ABL-Negative myeloproliferative neoplasms with correlation with janus-associated kinase 2 mutation
by: Roopa Dixith, et al.
Published: (2019-01-01)

Equitable access to diagnostic resources means one Xpert-Ultra cartridge for all inpatients with HIV being investigated for tuberculosis
by: T Boyles, et al.
Published: (2025-05-01)

Utility of stool Xpert MTB/Rif assay in the diagnosis of pulmonary and abdominal tuberculosis in children - A study from Western India
by: Ira Shah, et al.
Published: (2025-03-01)

Underutilisation of GeneXpert devices for TB diagnosis: a missed opportunity
by: J. Dörfler, et al.
Published: (2025-07-01)

Acute Myeloid Leukemia with Concomitant BCR-ABL and NPM1 Mutations
by: Benedetta Mariotti, et al.
Published: (2019-01-01)

Evaluating the performance of the Xpert HPV assay in detecting HPV positive cases in Morocco
by: Said Ali Yerim, et al.
Published: (2025-06-01)

From the bench of molecular understanding to the bedside of optimal therapy for BCR::ABL1 and ABL-class acute lymphoblastic leukemia in children and adolescents
by: Sarah K. Tasian, et al.
Published: (2025-12-01)

CLINICAL CASE OF TREATMENT OF A PATIENT WITH CHRONIC MYELOID LEUKEMIA WITH A MUTATION BCR-ABL Y253H AND COMORBIDITIES
by: G. Sh. Safuanova, et al.
Published: (2019-05-01)

Uncommon phenotypes of <i>BCR::ABL1</i>-positive chronic myelogenous leukemia: a review
by: Audrey N. Jajosky, et al.
Published: (2025-05-01)

BCR-ABL gene amplification in patients with chronic myeloid leukemia and imatinib resistance
by: S. I. Kutzev, et al.
Published: (2022-11-01)

A Novel BCR::ABL1 Variant Detected with Multiple Testing Modalities
by: J. Jean, et al.
Published: (2024-01-01)

Identification of rare atypical BCR-ABL1 transcript: A case report
by: Jayesh Saha, et al.
Published: (2023-07-01)

Development of mirror-image monobodies targeting the oncogenic BCR::ABL1 kinase
by: Nina Schmidt, et al.
Published: (2024-12-01)

Prognostic Significance of Transcript-Type BCR‐ABL1 in Chronic Myeloid Leukemia
by: matteo molica, et al.
Published: (2020-08-01)

Accuracy of the InnowaveDX MTB/RIF test for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre study
by: Yunfeng Deng, et al.
Published: (2023-12-01)

Copy number variation analysis in cytochromes and glutathione S-transferases may predict efficacy of tyrosine kinase inhibitors in chronic myeloid leukemia.
by: Alexander V Lavrov, et al.
Published: (2017-01-01)

Dual EGFR and ABL Tyrosine Kinase Inhibitor Treatment in a Patient with Concomitant EGFR-Mutated Lung Adenocarcinoma and BCR-ABL1-Positive CML
by: Kousuke Watanabe, et al.
Published: (2020-01-01)

Expression of the BCR-ABL1 Gene in Patients with Chronic Myeloproliferative Diseases with Signs of Progression
by: LA Kesaeva, et al.
Published: (2018-10-01)

CDK6 kinase inhibition unmasks metabolic dependencies in BCR::ABL1+ leukemia
by: Lisa Scheiblecker, et al.
Published: (2025-02-01)

Evaluation of the Gene Xpert Mycobacterium tuberculosis/resistance to rifampicin assay in rapid diagnosis of tuberculosis and identification of rifampin resistance in tuberculous patients
by: Amal H.G. Hamed, et al.
Published: (2025-01-01)

IMPACT OF EXPRESS SUSCEPTIBILITY TESTING TO RIFAMPICIN OF M. TUBERCULOSIS ON CHEMOTHERAPY EFFICIENCY IN THOSE SUFFERING FROM MULTIPLE DRUG RESISTANT TUBERCULOSIS
by: A. G. Samoylova, et al.
Published: (2016-09-01)

Evaluating the accuracy of HIV-1 viral load testing using near point of care Xpert HIV-1 system at Solwezi general hospital, Zambia
by: Keembe Siakantu, et al.
Published: (2025-07-01)